This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Peer Reviewed Article Puts The Focus On Infections From Conventional Endoscopes

Stocks in this article: VSCI

Vision-Sciences' EndoSheath ® Technology Offers a Solution

ORANGEBURG, N.Y., April 3, 2014 (GLOBE NEWSWIRE) -- A recent peer reviewed article published March 19, 2014 in The BMJ* by Steve Brozak and Anne Marie Noronha again establishes a case for an alternative to the conventional endoscope cleaning process and reviews why conventional cleaning puts patients at risk of infection. The publication, " A 21st century nosocomial issue with endoscopes," identifies the sterile, disposable EndoSheath ® Technology from Vision-Sciences as a safe, cost-effective alternative to conventional flexible endoscopes.

Key points stated in the BMJ article:

  • Reprocessing conventional flexible endoscopes is "time consuming, labor intensive, expensive and, most importantly, susceptible to failure."
  • Due to "limited surveillance, limited reporting, and lack of immediate clinical symptoms of patients," experts agree that cross-contamination is significantly under-reported.
  • Infections "resulting from scope contamination breaks the trust between patients and doctors and places a financial burden on healthcare institutions."
  • Research shows that using EndoSheath Technology and its simplified cleaning and disinfection procedure offers "a vast improvement over current decontamination procedures."
  • EndoSheath Technology eliminates "unreliable and cumbersome reprocessing" of conventional endoscopes by condensing the protocol into just a few steps, and "reduces reprocessing time by up to 31 minutes."
  • Due to its design, EndoSheath Technology is "more cost effective, reduces repair costs, and decreases investment in multiple scopes that are out of operation while being cleaned."

On a recent interview on "Taking Stock with Pimm Fox," Cheryl Pegus, M.D., the lead independent director of the Board of Directors of Vision-Sciences, Inc. (Nasdaq:VSCI), says , "It's really about how do we prevent infections and Vision-Sciences technology is frankly at the right place at the right time, because we can prevent infections in endoscopy."

See Dr. Pegus on "Taking Stock with Pimm Fox:"

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs